Ireland - English - HPRA (Health Products Regulatory Authority)

leo pharma a/s - sodium fusidate - impregnated dressing - 30 milligram(s) - medicated dressings with antiinfectives; fusidic acid - medicated dressings with antiinfectives - fucidin is indicated for the treatment of skin infections caused by bacteria susceptible to sodium fusidate in children from 1 year of age and adults. consideration should be given to official guidance on the appropriate use of antibacterial agents. prescribers should consider local resistance and susceptibility.

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - sodium fusidate, quantity: 250 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; titanium dioxide; lactose monohydrate; crospovidone; hypromellose; microcrystalline cellulose; purified talc; magnesium stearate; dl-alpha-tocopherol - treatment of localised, as well as generalised, staphylococcal infections caused by susceptible organisms. in severe infections, deep-seated infections, infections due to methicillin-resistant staphylococci or when prolonged therapy may be required, fucidin must be given concurrently with other anti-staphylococcal antibiotic therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - sodium fusidate, quantity: 20 mg/g - ointment - excipient ingredients: white soft paraffin; cetyl alcohol; wool fat; liquid paraffin - skin lesions primarily and secondarily infected with staphylococci, e.g. abscesses, boils, furunculosis, impetigo, folliculitis, hidradenitis, pyoderma, sycosis barbae, otitis externa.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl limited - sodium fusidate -

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - sodium fusidate - ointment - 20 mg/g - sodium fusidate 20 mg/g

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - sodium fusidate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - sodium fusidate -

Australia - English - Department of Health (Therapeutic Goods Administration)

csl limited - sodium fusidate -

New Zealand - English - Medsafe (Medicines Safety Authority)

leo pharma limited - sodium fusidate 250mg; sodium fusidate 250mg - film coated tablet - 250 mg - active: sodium fusidate 250mg excipient: colloidal silicon dioxide crospovidone gelatin hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc titanium dioxide active: sodium fusidate 250mg excipient: colloidal silicon dioxide crospovidone dl-alpha tocopheryl acetate hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose purified talc titanium dioxide - treatment of localised as well as generalised staphylococcal infections (e.g. abscesses, furunculosis, wound infections, pneumonia, peritonitis, osteomyelitis, septicaemia, enteritis and otorhinolaryngeal infections).

Israel - English - Ministry of Health

dexcel ltd, israel - fusidic acid - cream - fusidic acid 20 mg/g - fusidic acid - fusidic acid - local treatment of skin infections due to sensitive strains of staphylococus aureus.